Lipase
is an enzyme, which helps in the hydrolysis of fats and reduces the
formation of glycerol and fatty acids in all living beings. It plays
a vital role in the process of digestion by transporting and
processing the ester bonds in triglycerides. In addition, it helps in
the keeping of pancreatic enzymes to an optimum level. Health
disorders such as bloating, indigestion and abdominal discomfort are
caused by the consumption of high carbohydrate and fatty food items.
Lipases help in the prevention of diabetes, cholesterol, obesity and
high triglycerides. Lipases are generally produced with the help of
microbial sources such as fungi, yeast and bacteria. Bacteria and
fungi lipases are preferred the most in the enzymes industry.
Microbial lipases can be more effective than lipases that are
obtained from animals and plants because of its variety in high
yield, ease of genetic modification and catalytic activities.
Lipase
is one of the largest growing markets in the enzymes market due to
its health and industrial advantages. In food and non food
industries, lipases are used as shelf life enhancers, flavorants,
texturants and cleaning agents. Lipases also find huge application in
animal feeds, where it is used in improving the health of livestock.
In addition, lipases are used for medical and diagnostic use. Blood
test with the help of lipase can help detect acute pancreatitis and
other disorders in the pancreas of human body. Lipases also assist
patients undergoing pancreatic enzyme replacement therapy (PERT),
where it helps in the breakdown of fats into lipids.
Rise
in the consumption of processed dairy products and meat and
increasing awareness of animal health are the major driving factors
of the global
lipase market. In addition, multiple health benefits
associated with the use of lipase in human bodies is also set to
bolster the global lipase market. The restraint inhibiting the global
lipase market is the lack of transparency in the law of patent
protection across the globe.
The
global lipase market has been segmented by source, which includes
animal lipases and microbial lipases. In addition, the market has
been categorized by application, which includes animal feed, dairy,
bakery, confectionary and others. By geography, it has been segmented
into North America, Europe, Asia Pacific, Latin America and Rest of
the World (RoW).
In
the global lipase market, Asia Pacific witnessed the largest revenue
in 2014, and by the end of the forecast period from 2015 to 2023,
Asia Pacific is expected to show significant growth. Countries in the
Asia Pacific such as India, China and Japan are the considered to be
the largest growing markets in the region. The Asia Pacific lipase
market is followed by North America, Europe, Latin America and Rest
of the World (RoW).
For
more information on this report, fill the form @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7942
Some
of the key players in the global lipase market include Amano Enzymes
Inc., Novozymes A/S, Chr. Hansen Holdings A/S, E. I. du Pont Nemours
and Company, Koninklijke DSM N.V., Renco New Zealand, Clerici-Sacco
Group, Associated British Foods Plc and Advanced Enzymes among
others.
No comments:
Post a Comment